Dose independent pharmacokinetics of mexiletine in healthy volunteers
- PMID: 3964531
- PMCID: PMC1400855
- DOI: 10.1111/j.1365-2125.1986.tb05196.x
Dose independent pharmacokinetics of mexiletine in healthy volunteers
Abstract
In 12 healthy volunteers who received orally 100, 200, 300, 400 and 600 mg mexiletine at weekly intervals, the maximum plasma concentration of mexiletine and AUC increased linearly with the dose of mexiletine. Between doses there were no significant differences in the values for clearance and volume of distribution of mexiletine but there were for plasma elimination half-life. These results indicate that the kinetics of mexiletine are linear.
Similar articles
-
The clinical pharmacology of mexiletine.Br J Clin Pharmacol. 1978 Aug;6(2):103-8. doi: 10.1111/j.1365-2125.1978.tb00833.x. Br J Clin Pharmacol. 1978. PMID: 678385 Free PMC article.
-
Pharmacokinetics of mexiletine in renal insufficiency.Acta Cardiol Suppl. 1980;(25):55-65. Acta Cardiol Suppl. 1980. PMID: 6966453
-
Plasma mexiletine concentrations following combined oral and intramuscular administration.Eur J Clin Pharmacol. 1981 Mar;19(4):301-4. doi: 10.1007/BF00562808. Eur J Clin Pharmacol. 1981. PMID: 7286033
-
Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.Drugs. 1979 Mar;17(3):161-81. doi: 10.2165/00003495-197917030-00003. Drugs. 1979. PMID: 378646 Review.
-
Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine.Acta Cardiol Suppl. 1980;(25):45-53. Acta Cardiol Suppl. 1980. PMID: 6990666 Review.
Cited by
-
Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.Drugs. 1990 Sep;40(3):374-411. doi: 10.2165/00003495-199040030-00005. Drugs. 1990. PMID: 2226221 Review.
-
Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.Drugs. 1998 Oct;56(4):691-707. doi: 10.2165/00003495-199856040-00016. Drugs. 1998. PMID: 9806111 Review.
-
Clinical pharmacokinetics of mexiletine.Clin Pharmacokinet. 1999 Nov;37(5):361-84. doi: 10.2165/00003088-199937050-00002. Clin Pharmacokinet. 1999. PMID: 10589372 Review.
-
Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double-blind placebo-controlled cross-over study.Clin Transl Sci. 2022 Dec;15(12):2971-2981. doi: 10.1111/cts.13418. Epub 2022 Oct 25. Clin Transl Sci. 2022. PMID: 36281627 Free PMC article. Clinical Trial.
-
Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.Clin Pharmacokinet. 1991 Feb;20(2):151-66. doi: 10.2165/00003088-199120020-00006. Clin Pharmacokinet. 1991. PMID: 2029806 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources